Norwegian version of this page

PharmacoEpidemiology and Drug Safety (PharmaSafe)

Medications are an essential aspect of health care. The PharmacoEpidemiology & Drug Safety Research Group (PharmaSafe) covers a wide range of research activities related to optimal use and safety of medication on an individual and societal level. We use epidemiological methods to address questions of drug safety that cannot be studies in randomized controlled trials (RCTs). Our work includes monitoring of drug utilization in pregnancy, perception towards medicines, methodology research, analysis of medication safety on patient outcomes and health economics.

The research group is multidiciplinary and has expertise in pharmacoepidemiology and drug safety, biostatistics, health economics and pharmacotherapy.


  • mollie NFR Young Research Talent grant to Mollie Wood! Dec. 19, 2019 1:11 PM


  • theaarhusteam PharmaSafe at NorPEN Nov. 18, 2019 11:47 AM

    Hedvig, Sarah and Anders represented PharmaSafe at the NorPEN meeting in Aarhus 14th to 15th November 2019 in Aarhus.

  • anne_gloersen Anne Gyri Gløersen joins PharmaSafe Nov. 1, 2019 7:00 AM

    Today Anne Gyri Gløersen joins PharmaSafe. Welcome! Below, Anne Gyri presents herself.

  • colourbox12147274 Two new “real-world” pharmacists strengthen the Social Pharmacy staff! Oct. 29, 2019 10:16 AM

    Clinical skills and communication are essential in training the futures pharmacists. We are very proud to strengthen our staff in Social Pharmacy with two “real-world” pharmacists. Below they present themselves. Welcome Vedrana and Hassina!!

  • anne-gerd-granas Anne Gerd Granås er Årets Farmasøyt 2019 Oct. 5, 2019 6:25 AM

    Årets Farmasøyt er en utmerkelse som gis til en yrkesaktiv farmasøyt som på en spesiell måte har bidratt til å forsterke, utvikle eller befeste farmasiens og farmasøytenes rolle i samfunnet, og som gjennom sin yrkesutøvelse står som et forbilde for andre farmasøyter.

    Les juryens begrunnelse nedenfor.

Published Oct. 21, 2013 12:16 PM - Last modified Nov. 27, 2019 10:58 AM